Anti-SARS-CoV-2 mRNA vaccine in patients with rheumatoid arthritis

Rubbert-Roth, Andrea; Vuilleumier, Nicolas; Ludewig, Burkhard; Schmiedeberg, Kristin; Haller, Christoph; von Kempis, Johannes

doi:10.1016/s2665-9913(21)00186-7

Scientific article

Comment

English

Anti-SARS-CoV-2 mRNA vaccine in patients with rheumatoid arthritis

ContributorsRubbert-Roth, Andrea; Vuilleumier, Nicolas; Ludewig, Burkhard; Schmiedeberg, Kristin; Haller, Christoph; von Kempis, Johannes

Published inThe Lancet. Rheumatology, vol. 3, no. 7, p. e470-e472

Publication date2021-07

First online date2021-06-08

Affiliation entities

Faculté de médecine / Section de médecine clinique / Département de médecine

Research groups

Auto-immunité, inflammation et athérosclérose (270)

Citation (ISO format)

RUBBERT-ROTH, Andrea et al. Anti-SARS-CoV-2 mRNA vaccine in patients with rheumatoid arthritis. In: The Lancet. Rheumatology, 2021, vol. 3, n° 7, p. e470–e472. doi: 10.1016/s2665-9913(21)00186-7

Article (Published version)

Identifiers

PID : unige:157631
DOI : 10.1016/s2665-9913(21)00186-7
PMID : 34124693
PMCID : PMC8186851

Additional URL for this publicationhttps://linkinghub.elsevier.com/retrieve/pii/S2665991321001867

Journal ISSN2665-9913

152views

110downloads

Creation11/17/2021 3:20:00 PM

First validation11/17/2021 3:20:00 PM

Update time01/23/2025 11:25:49 AM

Status update01/23/2025 11:25:49 AM

Last indexation01/23/2025 11:34:03 AM

Archive ouverte UNIGE

Anti-SARS-CoV-2 mRNA vaccine in patients with rheumatoid arthritis

Technical informations